Knowledge Center
Poster / Dec 06, 2017
Ultrasonic versus Two-Fluid Nozzle in a Spray Drying Process
Source:
DDL 2017
When developing a dry powder inhaler formulation (DPI) for a biopharmaceutical two main aspects should be considered:
- Powder Aerodynamic Performance;
- Biopharmaceutical Integrity:
Thus...
Particle Engineering Technology plays a pivotal role - Spray Drying (SD) emerges as a viable candidate
- From an inhalation standpoint: Relative simplicity, cost effectiveness and scalability with increased control over key aerosol features;
- From a biopharmaceutical standpoint: Mild Temperature exposure, commercial availability of miniaturized SD set-ups;
However,
Spray Drying atomization step might constitute a stress source for the processed biopharmaceutical, ultimately causing its degradation:
- On conventional lab-scale spray dryers, this atomization step is performed using Two-Fluid (2F) Nozzle atomizers that produce a turbulent spray;
- Ultrasonic (US) Nozzle atomizers, on the other hand, produce a low velocity spray that could be envisaged as a possible alternative.
Related links
Also in the Knowledge Center
/ Jan 11, 2024
Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
Read more
Scientific Article
/ Nov 12, 2024
Webinar - Solving the Insoluble: Webinar on the Science and Application of the Dispersome® Technology
Read more
Scientific Article
/ Oct 29, 2024
Comparison of Traditional and Mechanochemical Production Processes for Nine Active Pharmaceutical Ingredients (APIs)
Read more
Scientific Article